Inventor · disambiguated record
Steven S. Clareen
Also filed as: CLAREEN STEVEN · CLAREEN STEVEN S · CLAREEN STEVEN SPENCER
7 granted patents·2 pending applications·220 citations·filing 2006–2015
89Inventor score
Technology areasA61P
Top patents by PatentIndex Score
9 records- 0195US8383634B2Methods of treatment using heteroaryl compounds and compositions thereofSIGNAL PHARM LLC·Filed 2011·Granted Feb 26, 2013·46 cites·4 claims
- 0295US7968556B2Heteroaryl compounds, compositions thereof, and methods of treatment therewithSIGNAL PHARM LLC·Filed 2007·Granted Jun 28, 2011·41 cites·3 claims
- 0395US7723340B2Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewithSIGNAL PHARM LLC·Filed 2006·Granted May 25, 2010·46 cites·51 claims
- 0494US7521446B2Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewithSIGNAL PHARM LLC·Filed 2006·Granted Apr 21, 2009·39 cites·60 claims
- 0593US9187479B2Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewithSIGNAL PHARM LLC·Filed 2014·Granted Nov 17, 2015·17 cites·12 claims
- 0692US9725450B2Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewithSIGNAL PHARM LLC·Filed 2015·Granted Aug 8, 2017·9 cites·9 claims
- 0788US8101588B2Haloaryl substituted aminopurines, compositions thereof, and methods of treatment therewithALBERS RONALD J·Filed 2009·Granted Jan 24, 2012·22 cites·29 claims
- 0860US2009312320A1Methods of treatment comprising the administration of haloaryl substituted aminopurines or compositions thereofSIGNAL PHARM LLC·Filed 2009·Application pending·0 cites
- 0960US2013225564A1Haloaryl substituted aminopurines, compositions thereof,and methods of treatment therewithSIGNAL PHARM LLC·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Steven S. Clareen files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →